骨骼肌
肌生成抑制素
医学
肌萎缩
浪费的
背景(考古学)
恶病质
生物信息学
物理医学与康复
内分泌学
内科学
生物
癌症
古生物学
作者
Ravi Jasuja,Nathan K. LeBrasseur
出处
期刊:American Journal of Physical Medicine & Rehabilitation
[Ovid Technologies (Wolters Kluwer)]
日期:2014-11-01
卷期号:93 (11): S88-S96
被引量:18
标识
DOI:10.1097/phm.0000000000000118
摘要
Skeletal muscle is a fundamental organ in the generation of force and movement, the regulation of whole-body metabolism, and the provision of resiliency. Indeed, physical medicine and rehabilitation is recognized for optimizing skeletal muscle health in the context of aging (sarcopenia) and disease (cachexia). Exercise is, and will remain, the cornerstone of therapies to improve skeletal muscle health. However, there are now a number of promising biologic and small molecule interventions currently under development to rejuvenate skeletal muscle, including myostatin inhibitors, selective androgen receptor modulators, and an activator of the fast skeletal muscle troponin complex. The opportunities for skeletal muscle-based regenerative therapies and a selection of emerging pharmacologic interventions are discussed in this review.
科研通智能强力驱动
Strongly Powered by AbleSci AI